Roger M. Lyons

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

David J. Kuter, James B. Bussel, Roger M. Lyons et al. · The Lancet · 2008 · 851 citations

Thrombopoiesis, Thrombosis, Autoimmune Disease +9

AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP

James B. Bussel, David J. Kuter, James N. George et al. · New England Journal of Medicine · 2006 · 526 citations · Full text

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

James B. Bussel, David J. Kuter, Vinod Pullarkat et al. · Blood · 2008 · 430 citations · Full text

Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period

Steven R. Deitcher, Craig M. Kessler, Geno J. Merli et al. · Clinical and Applied Thrombosis/Hemostasis · 2006 · 392 citations

Active Cancer, Pharmacotherapy, Cancer Patients +17